Article in Protein & cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Jingjing LiuDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Tao ZhengCAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0001-5218-4161
Xiangxi WangCAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0003-0635-278X
Yuhua LiDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Yao SunCAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0001-6892-4996
Ling ZhuCAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Funding
Chinese Academy of Sciences YSBR-010Jiangsu Province Science and Technology Achievement Transformation Special Project BA2023012Ministry of Science and Technology of China CPL-1233Ministry of Science and Technology of China SRPG22-003National Key Research and Development Program of China 2018YFA0900801National Key Research and Development Program of China 2023YFC2306603National Natural Science Foundation of China 12034006National Natural Science Foundation of China 32200135National Natural Science Foundation of China 32200138National Natural Science Foundation of China 32371286National Natural Science Foundation of China T2394480National Natural Science Foundation of China T2394482National Science Fund for Distinguished Young Scholars No. 32325004NSFC Innovative Research Group No. 81921005
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
An improved method for the detection of double-stranded RNA suitable for quality control of mRNA vaccines. · full record | OpenQuestion